• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肝切除患者早期和晚期复发的预测因素及长期预后:一项大规模多中心研究

Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.

作者信息

Yan Wen-Tao, Li Chao, Yao Lan-Qing, Qiu Hai-Bo, Wang Ming-Da, Xu Xin-Fei, Zhou Ya-Hao, Wang Hong, Chen Ting-Hao, Gu Wei-Min, Zhong Jian-Hong, Wu Han, Pawlik Timothy M, Lau Wan Yee, Shen Feng, Yang Tian

机构信息

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, China.

Graduate School, Second Military Medical University (Navy Medical University), Shanghai, China.

出版信息

Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):155-168. doi: 10.21037/hbsn-21-288. Epub 2021 Oct 21.

DOI:10.21037/hbsn-21-288
PMID:37124678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10129892/
Abstract

BACKGROUND

Recurrence is common among patients undergoing hepatic resection for hepatocellular carcinoma (HCC), which greatly limits long-term survival. We aimed to identify predictors and long-term prognosis of early and late recurrence after HCC resection.

METHODS

Multicenter data of patients who underwent HCC resection between 2002 and 2016 were analyzed. Recurrence was divided into early (≤2 years) and late recurrence (>2 years after surgery). Predictors of early and late recurrence, and prognostic factors of post-recurrence survival (PRS) were identified by univariate and multivariate analyses.

RESULTS

Among 1,426 patients, 554 (38.8%) and 348 (24.4%) developed early and late recurrence, respectively. Independent predictors associated with early recurrence included preoperative alpha-fetoprotein level >400 µg/L, resection margin <1 cm, and tumor size >5.0 cm, multiplicity, macrovascular and microvascular invasion, and satellites of the initial tumor at the first diagnosis of HCC; independent predictors associated with late recurrence included male, cirrhosis, and tumor size >5.0 cm, multiplicity, macrovascular and microvascular invasion, and satellites of the initial tumor. Patients with early recurrence had a lower likelihood of undergoing potentially curative treatments for recurrence (37.2% 48.0%, P<0.001) and a worse median PRS (13.5 36.6 months, P<0.001) patients who had late recurrence. Multivariate analysis revealed that early recurrence and irregular postoperative surveillance were independently associated with worse PRS [hazard ratio (HR) =1.250, 95% CI: 1.016-1.538, P=0.035; and HR =1.983, 95% CI: 1.677-2.345, P<0.001].

CONCLUSIONS

Predictors associated with early and late recurrence after curative resection for patients with HCC were generally same, although several did differ. Patients with late recurrence had better long-term survival than patients with early recurrence.

摘要

背景

肝细胞癌(HCC)肝切除术后复发常见,这极大地限制了长期生存。我们旨在确定HCC切除术后早期和晚期复发的预测因素及长期预后。

方法

分析2002年至2016年间接受HCC切除患者的多中心数据。复发分为早期(≤2年)和晚期复发(术后>2年)。通过单因素和多因素分析确定早期和晚期复发的预测因素以及复发后生存(PRS)的预后因素。

结果

1426例患者中,分别有554例(38.8%)和348例(24.4%)发生早期和晚期复发。与早期复发相关的独立预测因素包括术前甲胎蛋白水平>400μg/L、切缘<1cm、肿瘤大小>5.0cm、肿瘤多发、大血管和微血管侵犯以及首次诊断HCC时初始肿瘤的卫星灶;与晚期复发相关的独立预测因素包括男性、肝硬化、肿瘤大小>5.0cm、肿瘤多发、大血管和微血管侵犯以及初始肿瘤的卫星灶。早期复发患者接受复发潜在根治性治疗的可能性较低(37.2%对48.0%,P<0.001),且PRS的中位生存期较差(13.5对36.6个月,P<0.001),晚期复发患者则相反。多因素分析显示,早期复发和术后不规则监测与较差的PRS独立相关[风险比(HR)=1.250,95%置信区间:1.016 - 1.538,P = 0.035;HR = 1.983,95%置信区间:1.677 - 2.345,P<0.001]。

结论

HCC根治性切除术后早期和晚期复发的预测因素总体相同,尽管有一些确实不同。晚期复发患者的长期生存优于早期复发患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/1c8ba80732e5/hbsn-12-02-155-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/3e2cba45c0b4/hbsn-12-02-155-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/47f11fd2f468/hbsn-12-02-155-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/1c8ba80732e5/hbsn-12-02-155-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/3e2cba45c0b4/hbsn-12-02-155-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/47f11fd2f468/hbsn-12-02-155-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c52a/10129892/1c8ba80732e5/hbsn-12-02-155-f3.jpg

相似文献

1
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.肝细胞癌肝切除患者早期和晚期复发的预测因素及长期预后:一项大规模多中心研究
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):155-168. doi: 10.21037/hbsn-21-288. Epub 2021 Oct 21.
2
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.乙肝病毒相关性肝细胞癌的早发和晚发复发。
Oncologist. 2020 Oct;25(10):e1541-e1551. doi: 10.1634/theoncologist.2019-0944. Epub 2020 Jun 9.
3
Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis.早期肝细胞癌肝切除术后复发的临床特征及复发患者的长期生存结果:一项多机构分析
Ann Surg Oncol. 2022 Feb 22. doi: 10.1245/s10434-022-11454-y.
4
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
5
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.用于预测肝细胞癌根治性切除术后早期复发的术前血清肝酶标志物。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.
6
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.肝脏和脾脏硬度在预测肝癌切除术后复发中的作用。
J Hepatol. 2019 Mar;70(3):440-448. doi: 10.1016/j.jhep.2018.10.022. Epub 2018 Oct 31.
7
Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0/A hepatocellular carcinoma: A large-scale multicenter study.巴塞罗那临床肝癌分期 0/A 期肝癌切除术后超出米兰标准复发的危险因素和长期预后:一项大规模多中心研究。
Surgery. 2022 Oct;172(4):1147-1155. doi: 10.1016/j.surg.2022.05.023. Epub 2022 Jul 19.
8
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.多中心队列研究:肝切除治疗双叶型肝细胞肝癌的长期生存结果。
Oncologist. 2019 Aug;24(8):e730-e739. doi: 10.1634/theoncologist.2018-0898. Epub 2019 May 24.
9
HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.乙肝病毒脱氧核糖核酸和乙肝表面抗原水平作为乙肝相关肝细胞癌根治性切除术后早期和晚期复发的风险预测指标
Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
10
Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.基于复发后生存的手术切除后肝细胞癌早期与晚期复发的比较:一项国际多机构分析。
J Gastrointest Surg. 2021 Jan;25(1):125-133. doi: 10.1007/s11605-020-04553-2. Epub 2020 Mar 3.

引用本文的文献

1
Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter Study.肝细胞癌肝切除术后晚期复发个体化预测模型(POLAR-HCC)的开发与验证:一项多中心研究
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18213-9.
2
ASO Author Reflections: Reconsidering Late Recurrence After Hepatectomy for Hepatocellular Carcinoma: Insights from Predictive Modeling.ASO作者反思:重新审视肝细胞癌肝切除术后的晚期复发:预测模型的见解
Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18303-8.
3
Radiomics-based machine-learning method to predict extrahepatic metastasis in hepatocellular carcinoma after hepatectomy: a multicenter study.

本文引用的文献

1
Early versus late recurrence of centrally located hepatocellular carcinoma after mesohepatectomy: A cohort study based on the STROBE guidelines.肝中叶切除术后中央型肝细胞癌的早期与晚期复发:一项基于STROBE指南的队列研究
Medicine (Baltimore). 2019 Jun;98(23):e15540. doi: 10.1097/MD.0000000000015540.
2
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
3
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?肝癌患者术后预后是否存在性别差异?
基于影像组学的机器学习方法预测肝癌肝切除术后肝外转移:一项多中心研究
Sci Rep. 2025 Aug 14;15(1):29784. doi: 10.1038/s41598-025-15406-w.
4
Risk for Recurrence After Liver Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Detected After Sustained Virological Response by Direct-Acting Antivirals: A Retrospective Multicenter Study.直接抗病毒药物实现持续病毒学应答后检测出的丙型肝炎病毒相关性肝细胞癌患者肝切除术后的复发风险:一项回顾性多中心研究
Cancers (Basel). 2025 Jun 11;17(12):1946. doi: 10.3390/cancers17121946.
5
Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy.肝动脉灌注化疗联合阿帕替尼/卡瑞利珠单抗治疗肝切除术后复发性肝细胞癌
J Hepatocell Carcinoma. 2025 Jun 17;12:1205-1215. doi: 10.2147/JHC.S520430. eCollection 2025.
6
Adjuvant transarterial chemoembolization plus lenvatinib for patients with HCC with MVI after resection: a multicenter retrospective study.辅助性经动脉化疗栓塞联合乐伐替尼治疗肝癌切除术后伴微血管侵犯患者:一项多中心回顾性研究
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf139.
7
Effect of 15- or 25-min intermittent Pringle maneuver on early recurrence of hepatocellular carcinoma after hepatectomy: a protocol for a randomized controlled trial.15分钟或25分钟间歇性Pringle手法对肝切除术后肝细胞癌早期复发的影响:一项随机对照试验方案
Trials. 2025 Jun 4;26(1):194. doi: 10.1186/s13063-025-08897-5.
8
Changes in perioperative serum transaminase levels: predicting early recurrence after hepatectomy for hepatocellular carcinoma.围手术期血清转氨酶水平的变化:预测肝细胞癌肝切除术后的早期复发
Front Oncol. 2025 May 19;15:1589884. doi: 10.3389/fonc.2025.1589884. eCollection 2025.
9
Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation.预测接受不同疗程术后辅助经动脉化疗栓塞患者早期复发的列线图的开发与验证
BMC Gastroenterol. 2025 Jun 2;25(1):422. doi: 10.1186/s12876-025-04023-6.
10
Vision transformer-based model can optimize curative-intent treatment for patients with recurrent hepatocellular carcinoma.基于视觉变换器的模型可以优化复发性肝细胞癌患者的根治性治疗。
Nat Commun. 2025 May 1;16(1):4081. doi: 10.1038/s41467-025-59197-0.
BMC Cancer. 2019 Mar 20;19(1):250. doi: 10.1186/s12885-019-5453-3.
4
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
5
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.米兰标准以外的肝细胞癌切除术后复发预测:一项国际队列临床风险评分的验证
Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.
6
Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.根治性肝切除术后肝细胞癌肝外转移的预测独立因素
Anticancer Res. 2017 May;37(5):2625-2631. doi: 10.21873/anticanres.11609.
7
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.2000年至2012年美国50个州肝细胞癌的发病率
Gastroenterology. 2017 Mar;152(4):812-820.e5. doi: 10.1053/j.gastro.2016.11.020. Epub 2016 Nov 23.
8
Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.维生素K拮抗剂-II诱导蛋白作为生物标志物在肝细胞癌中的临床应用
Tumour Biol. 2016 Dec;37:15447–15456. doi: 10.1007/s13277-016-5443-x. Epub 2016 Oct 13.
9
Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.术前基于炎症的标志物可预测根治性肝切除术后肝细胞癌的早期和晚期复发。
Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):266-74. doi: 10.1016/s1499-3872(16)60094-2.
10
Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.移植后肝细胞癌复发:血管分布与分化程度之间的模式及关系
World J Hepatol. 2015 Feb 27;7(2):276-84. doi: 10.4254/wjh.v7.i2.276.